[HTML][HTML] Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up

V Kouloulias, S Triantopoulou, J Vrouvas… - Acta …, 2014 - ncbi.nlm.nih.gov
The purpose of our study was to test the efficacy and toxicity of hyperthermia in conjunction
with chemoradiotherapy for T3N0 laryngeal cancer. From 1997-2006, 25 patients diagnosed …

Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up

V Kouloulias, S Triantopoulou, J Vrouvas… - Acta …, 2014 - actaitalica.it
The purpose of our study was to test the efficacy and toxicity of hyperthermia in conjunction
with chemoradiotherapy for T3N0 laryngeal cancer. From 1997-2006, 25 patients diagnosed …

Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up

V Kouloulias, S Triantopoulou… - … Societa italiana di …, 2014 - pubmed.ncbi.nlm.nih.gov
The purpose of our study was to test the efficacy and toxicity of hyperthermia in conjunction
with chemoradiotherapy for T3N0 laryngeal cancer. From 1997-2006, 25 patients diagnosed …

Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.

V Kouloulias, S Triantopoulou, J Vrouvas… - … Organo Ufficiale Della …, 2014 - europepmc.org
The purpose of our study was to test the efficacy and toxicity of hyperthermia in conjunction
with chemoradiotherapy for T3N0 laryngeal cancer. From 1997-2006, 25 patients diagnosed …

Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.

V Kouloulias, S Triantopoulou, J Vrouvas… - … Organo Ufficiale Della …, 2014 - europepmc.org
The purpose of our study was to test the efficacy and toxicity of hyperthermia in conjunction
with chemoradiotherapy for T3N0 laryngeal cancer. From 1997-2006, 25 patients diagnosed …